Mounjaro (tirzepatide)

At a glance

Molecule

tirzepatide

Approved for

type 2 diabetes

Form

weekly injection

Self-pay, direct from manufacturer

from $499/month

Prescription required

Yes — as for every GLP-1 receptor agonist

The confusion worth clearing up

Mounjaro and Zepbound are the same molecule. If you are looking for the weight-management approval, that is Zepbound.

The class, the molecule and the brand name are three different levels, and most “versus” questions in this category dissolve once they are separated — which level of that Mounjaro belongs to, and what it is being compared against is the thing worth settling first.

What it costs

LillyDirect self-pay pricing.

Verified 2026-07-25 against Eli Lilly. Prices in this category change frequently — confirm before you buy.

That is the manufacturer’s direct price. How it compares against insurance, Medicare and telehealth memberships — which carry a membership fee on top of the medication — is set out in the same figure reached four other ways.

Price is one of the few things about Mounjaro that belongs to the molecule rather than to the brand. tirzepatide is sold in more than one form, and which form is prescribed moves the figure before any seller does. Where Mounjaro sits against every tirzepatide price we have verified is set out form by form, with each provider’s membership fee added to its medication price.

What this page deliberately leaves out

Side-effect rates, contraindications, dosing schedules, and drug interactions for Mounjaro are on its FDA-approved label, published on DailyMed. We are not going to reproduce them here from anywhere else, because a drug page that looks complete but was assembled second-hand is more dangerous than one that is visibly partial.

What we do cover, at the level of the class rather than the product:

• Side effects — what is common, what is serious, and the boxed warning.
• Dosing and titration — why doses start low and climb, and what happens at each step.
• How these medications work — the four mechanisms, and why they also explain the side effects.

Questions people ask about Mounjaro

Is Mounjaro a GLP-1?

Yes. Mounjaro is tirzepatide, a GLP-1 receptor agonist, approved for type 2 diabetes and given as a weekly injection. "GLP-1" is the drug class; tirzepatide is the molecule; Mounjaro is the brand name that molecule is sold under for this use.

Is Mounjaro the same as Zepbound?

They are the same molecule — tirzepatide — approved for different uses. Mounjaro is approved for type 2 diabetes; Zepbound for chronic weight management. That difference is not pharmacological, but it decides how an insurer treats each one, which is usually the practical question hiding inside "which is better".

Do you need a prescription for Mounjaro?

Yes, in the United States, as for every GLP-1 receptor agonist. Anything sold as Mounjaro without a prescription is not Mounjaro, whatever the label says — and a product bought outside the prescribing chain carries none of the manufacturing verification the approved product does.

How much does Mounjaro cost?

Mounjaro is published at from $499 a month self-pay direct from the manufacturer, verified 2026-07-25. That figure is the manufacturer's published price, not what you will necessarily pay: insurance, telehealth membership fees and dose all change the total.

This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.